Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
July 23, 2013
The outcome of patients with low risk gestational trophoblastic neoplasia treated with single agent intramuscular methotrexate and oral folinic acid
F Taylor, T Grew, J Everard, et al.
Gynecologic Oncology
|
October 21, 2016
Risk adapted single-agent dactinomycin or carboplatin for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia
M C Winter, J A Tidy, A Hills, et al.
Gynecologic Oncology
|
December 28, 2014
A retrospective study to evaluate single agent methotrexate treatment in low risk gestational choriocarcinoma in the United Kingdom
F Taylor, D Short, M C Winter, et al.
BJOG : an International Journal of Obstetrics and Gynaecology
|
January 17, 2016
Late spontaneous resolution of persistent molar pregnancy
F Taylor, D Short, R Harvey, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
January 27, 2019
Do we need post-pregnancy screening with human chorionic gonadotrophin after previous hydatidiform mole to identify patients with recurrent gestational trophoblastic disease?
K E Earp, B W Hancock, D Short, et al.
British Journal of Cancer
|
March 18, 2010
The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer
R E Coleman, M C Winter, D Cameron, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 8, 2019
The results of treatment with high-dose chemotherapy and peripheral blood stem cell support for gestational trophoblastic neoplasia
M M Frijstein, C A R Lok, D Short, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 2, 2016
Effects of neoadjuvant chemotherapy with or without zoledronic acid on pathological response: A meta-analysis of randomised trials
J R Kroep, A Charehbili, R E Coleman, et al.
Gynecologic Oncology
|
November 27, 2018
Management and prognostic factors of epithelioid trophoblastic tumors: Results from the International Society for the Study of Trophoblastic Diseases database
M M Frijstein, C A R Lok, N E van Trommel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 24, 2022
Results of the c-TRAK TN trial: a clinical trial utilising ctDNA mutation tracking to detect molecular residual disease and trigger intervention in patients with moderate- and high-risk early-stage triple-negative breast cancer
N C Turner, C Swift, B Jenkins, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
European Journal of Cancer (Oxford, England : 1990)
|
July 23, 2013
The outcome of patients with low risk gestational trophoblastic neoplasia treated with single agent intramuscular methotrexate and oral folinic acid
F Taylor, T Grew, J Everard, et al.
Gynecologic Oncology
|
October 21, 2016
Risk adapted single-agent dactinomycin or carboplatin for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia
M C Winter, J A Tidy, A Hills, et al.
Gynecologic Oncology
|
December 28, 2014
A retrospective study to evaluate single agent methotrexate treatment in low risk gestational choriocarcinoma in the United Kingdom
F Taylor, D Short, M C Winter, et al.
BJOG : an International Journal of Obstetrics and Gynaecology
|
January 17, 2016
Late spontaneous resolution of persistent molar pregnancy
F Taylor, D Short, R Harvey, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
January 27, 2019
Do we need post-pregnancy screening with human chorionic gonadotrophin after previous hydatidiform mole to identify patients with recurrent gestational trophoblastic disease?
K E Earp, B W Hancock, D Short, et al.
British Journal of Cancer
|
March 18, 2010
The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer
R E Coleman, M C Winter, D Cameron, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 8, 2019
The results of treatment with high-dose chemotherapy and peripheral blood stem cell support for gestational trophoblastic neoplasia
M M Frijstein, C A R Lok, D Short, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 2, 2016
Effects of neoadjuvant chemotherapy with or without zoledronic acid on pathological response: A meta-analysis of randomised trials
J R Kroep, A Charehbili, R E Coleman, et al.
Gynecologic Oncology
|
November 27, 2018
Management and prognostic factors of epithelioid trophoblastic tumors: Results from the International Society for the Study of Trophoblastic Diseases database
M M Frijstein, C A R Lok, N E van Trommel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 24, 2022
Results of the c-TRAK TN trial: a clinical trial utilising ctDNA mutation tracking to detect molecular residual disease and trigger intervention in patients with moderate- and high-risk early-stage triple-negative breast cancer
N C Turner, C Swift, B Jenkins, et al.
Page
of 4